Edition:
United Kingdom

Allakos Inc (ALLK.OQ)

ALLK.OQ on NASDAQ Stock Exchange Global Select Market

44.35USD
24 May 2019
Change (% chg)

$0.68 (+1.56%)
Prev Close
$43.67
Open
$43.86
Day's High
$44.86
Day's Low
$43.52
Volume
53,239
Avg. Vol
100,450
52-wk High
$65.48
52-wk Low
$26.00

About

Allakos, Inc. is a clinical-stage biotechnology company, which is engaged in developing antibodies that selectively target mast cells and eosinophils. The Company's antibodies target receptor molecules present on the surface of immune effector cells, which are involved in allergy, inflammation and tissue damage. Its lead program... (more)

Overall

Beta: --
Market Cap(Mil.): $1,912.54
Shares Outstanding(Mil.): 43.12
Dividend: --
Yield (%): --

Financials

  ALLK.OQ Industry Sector
P/E (TTM): -- 31.10 35.45
EPS (TTM): -1.27 -- --
ROI: -43.55 12.04 11.75
ROE: -108.65 13.35 16.50

Earnings vs. Estimates